mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
OSU-03012 |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.005 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.099 |
0.006 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
0.09 |
0.006 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.007 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.007 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.007 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.007 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.007 |